FDA Drug Safety Communication: Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking certain GLP-1 receptor agonists
If you would like a personalized evaluation, you can request an appointment with our multidisciplinary team to determine which therapeutic option is most appropriate in your case.
NewsHealth Weight loss drug GLP-1 may have potential to treat depression, improve motivation, study suggests The blockbuster GLP-1 drugs taken by many Americans for diabetes and to aid in weight loss may also have potential for treating major depression, a new study finds
Impact on Weight Loss While both medications offer significant weight loss benefits, studies have shown that Tirzepatide often leads to greater weight reduction than Semaglutide
Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials